You are here:

Telmisartan/hydrochlorothiazide (MicardisPlus®)


Recommended for restricted use within NHS Scotland.


Telmisartan / hydrochlorothiazide (MicardisPlus®) has efficacy similar to the antihypertensive effects of the individual constituents added together in the treatment of essential hypertension. No increased costs are associated with this product compared with telmisartan (Micardis®) alone. Angiotensin II receptor antagonists are an alternative to ACE inhibitors where these are not tolerated.

Drug Details

Drug Name: Telmisartan/hydrochlorothiazide (MicardisPlus®)
SMC Drug ID: 39/03
Manufacturer: Boehringer Ingelheim Ltd
Indication: Essential hypertension
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Full submission
Status: Restricted
Date Advice Published: 9 May 2003